| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |